Literature DB >> 26620160

Diagnosis and therapy of acute disseminated encephalomyelitis and its variants.

Giulia Berzero1,2, Andrea Cortese1, Sabrina Ravaglia1, Enrico Marchioni1.   

Abstract

Acute disseminated encephalomyelitis (ADEM) is traditionally regarded as a monophasic demyelinating disorder of the central nervous system occurring in children after infection or vaccination. ADEM in children has a polysymptomatic presentation that includes encephalopathy, fever and meningeal signs. In adults, encephalopathy is less frequent and the clinical presentation is usually dominated by long tract involvement. Despite the initial clinical severity, the functional outcome is favorable in most cases. ADEM is a subgroup within the broader spectrum of postinfectious neurological syndromes (PINSs), which includes variants characterized by additional peripheral nervous system involvement, and variants characterized by a relapsing or chronic progressive course. The literature on the matter is scarce, mostly consisting of retrospective studies. The aims of this paper are to review the clinical and paraclinical profile of ADEM and its variants, to identify potential predictors of outcome, to summarize current treatment strategies and to outline research perspectives.

Entities:  

Keywords:  ADEM; Acute disseminated encephalomyelitis; CCPD; demyelination; postinfectious

Mesh:

Year:  2015        PMID: 26620160     DOI: 10.1586/14737175.2015.1126510

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  7 in total

1.  Acute disseminated encephalomyelitis following endonasal resection of a craniopharyngioma: illustrative case.

Authors:  Konrad Gag; Jonas Müller; Marie Süße; Robert Fleischmann; Henry W S Schroeder
Journal:  J Neurosurg Case Lessons       Date:  2021-10-18

2.  Clinical Presentation and Outcomes of Acute Disseminated Encephalomyelitis in Adults Worldwide: Systematic Review and Meta-Analysis.

Authors:  Kunyi Li; Maolin Li; Lan Wen; Qiancheng Wang; Xin Ding; Jian Wang
Journal:  Front Immunol       Date:  2022-06-09       Impact factor: 8.786

Review 3.  SARS-CoV-2-associated acute disseminated encephalomyelitis: a systematic review of the literature.

Authors:  Yumin Wang; Yanchao Wang; Liang Huo; Qiang Li; Jichao Chen; Hongquan Wang
Journal:  J Neurol       Date:  2021-08-30       Impact factor: 6.682

Review 4.  Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis.

Authors:  Nadja Borisow; Masahiro Mori; Satoshi Kuwabara; Michael Scheel; Friedemann Paul
Journal:  Front Neurol       Date:  2018-10-23       Impact factor: 4.003

5.  Clinicoradiological and prognostic features of COVID-19-associated acute disseminated encephalomyelitis.

Authors:  J Oumerzouk; M Nabil; R Klevor; S Belasri; M Chraa; N Louhab; N Kissani
Journal:  Rev Neurol (Paris)       Date:  2021-11-27       Impact factor: 2.607

6.  Antibody-negative autoimmune encephalitis as a complication of long-term immune-suppression for liver transplantation.

Authors:  Jeffrey Spindel; Matthew Heckroth; Luis Marsano
Journal:  BMJ Case Rep       Date:  2020-09-15

7.  Pseudotumoral Demyelinating Lesions: A Presentation of Acute Disseminated Encephalomyelitis.

Authors:  Rachid Belfkih; Omar Ghomari Khayat; Hind H'daidane; Fatima Zahra El Amrani
Journal:  Case Rep Neurol       Date:  2021-05-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.